Skip to main content
. 2011 Sep 20;26(4):335–346. doi: 10.1007/s12291-011-0150-2

Table 6.

Effect of GII (50 mg/kg bw) administration for 15 days on hexokinase and glucokinase in the liver, muscle and kidneys of the subdiabetic, moderately diabetic and severely diabetic rabbits

Hexokinase (u/g tissue) Liver Muscle Kidneys
Normal 0.7 ± 0.05 2.7 ± 0.2 0.9 ± 0.06
Subdiabetic untreated 0.62 ± 0.05 (9% fall from normal) 2.46 ± 0.1 (9% fall from normal) 0.9 ± 0.05 (no change)
Subdiabetic treated (change% from untreated) 0.67 ± 0.04 (+8%) 2.67 ± 0.1 (+8.5%) 0.9 ± 0.04 (no change)
Moderately diabetic untreated 0.46 ± 0.05 (34% fall from normal) 1.12 ± 0.12 (55%) fall from normal 0.9 ± 0.04 (no change)
Moderately diabetic treated (change% from untreated) 0.64 ± 0.04 (+39%) 1.54 ± 0.13 (+38%) 1.0 ± 0.04 (+11%)
Severely diabetic Untreated 0.47 ± 0.03 (34% fall from normal) 1.0 ± 0.1 (63% fall from normal) 0.77 ± 0.03 (14% fall from normal)
Severely diabetic treated (change% from untreated) 0.59 ± 0.04 (+25%) 1.47 ± 0.15 (+47%) 0.93 ± 0.05 (+21%)
Glucokinase (u/g tissue) Liver
Normal 1.7 ± 0.07
Subdiabetic untreated 0.68 ± 0.04 (60% fall from normal)
Subdiabetic treated (change% from untreated) 1.76 ± 0.08 (+159%)
Moderately diabetic untreated 0.32 ± 0.03 (81% fall from normal)
Moderately diabetic treated (change% from untreated) 1.68 ± 0.07 (+425%)
Severely diabetic untreated 0.35 ± 0.03 (79% fall from normal)
Severely diabetic treated (change% from untreated) 1.70 ± 0.08 (+386%)